SCHEMBL26286541

SCHEMBL26286541

c1ccc(-c2cc(-c3ccccc3-c3ccccc3-c3ccccc3-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)nc(-c3ccccc3)n2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 10/20 0.61
▸ KMT2A Q03164 10/20 0.61
▸ MAPT P10636 7/20 0.61
▸ ALDH1A1 P00352 6/20 0.61
▸ HPGD P15428 6/20 0.61
▸ NTSR1 P30989 1/20 0.56
▸ ADORA2A P29274 3/20 0.53
▸ ADORA1 P30542 3/20 0.53
▸ LMNA P02545 4/20 0.53
▸ KDM4E B2RXH2 3/20 0.53
▸ GLA P06280 1/20 0.53
▸ SMN1; SMN2 Q16637 3/20 0.49
▸ CYP2C19 P33261 3/20 0.49
▸ TDP1 Q9NUW8 2/20 0.49
▸ CYP1A2 P05177 2/20 0.49
▸ CYP2C9 P11712 2/20 0.49
▸ MAPK10 P53779 1/20 0.49
▸ L3MBTL1 Q9Y468 2/20 0.48
▸ MAPK1 P28482 1/20 0.47
▸ MAOB P27338 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18818825 0.98 MEN1 (0.63) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL18818826 0.94 MEN1 (0.68) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL24689406 0.89 MEN1 (0.61) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL18819169 0.89 MEN1 (0.67) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL18819167 0.89 MEN1 (0.67) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL30733540 0.88 MEN1 (0.60) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL21190677 0.88 MAOB (0.59) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL18818829 0.87 MEN1 (0.65) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL24689426 0.86 MEN1 (0.69) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL24689418 0.86 MEN1 (0.69) MEN1KMT2AMAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230301179-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-09-21 — — US disclosed
US-20230301179-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-09-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230301179-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE CRY1, AOX1, CYP1A1 MEN1 367/4885KMT2A 1497/4885MAPT 2220/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback